Literature DB >> 21978935

Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death.

Moon-Sun Jang1, Su-Jin Lee, Nam Sook Kang, Eunhee Kim.   

Abstract

Administration of the antimitotic chemotherapeutic taxol is known to cause accumulation of the mitotic kinase Aurora-A (Aur-A). Here, we report that Aur-A phosphorylates S203 of the Fas associated with death domain protein (FADD) in response to taxol treatment. In addition, polo-like kinase 1 (Plk1) failed to phosphorylate the Aur-A-unphosphorylatable FADD substitution mutant S203A, indicating that phosphorylation of S203 by Aur-A serves to prime FADD for Plk1-mediated phosphorylation at S194. The double-phosphorylation-mimicking mutant form of FADD, FADD-S194D/S203D (FADD-DD), recruited caspase-8, activating the caspase-dependent cell death pathway. FADD-DD also dissociated the cell death protein RIP1 from FADD, resulting in activation of RIP1 and triggering of caspase-independent cell death. Consistent with its death-promoting potential, FADD-DD showed robust tumor suppressor activity. However, single-phosphorylation-mimicking mutant forms of FADD, FADD-S194D/S203A (FADD-DA) and FADD-S194A/S203D (FADD-AD), were incapable of carrying out such functions, indicating that double phosphorylation of FADD is critical for the execution of cell death and tumor suppression. Collectively, our data show the existence of cooperative actions between Aur-A and Plk1 mitotic kinases in response to taxol, providing a molecular explanation for the action mechanism of taxol.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978935     DOI: 10.1158/0008-5472.CAN-11-0760

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.

Authors:  Brittany M Bowman; Katrina A Sebolt; Benjamin A Hoff; Jennifer L Boes; Danette L Daniels; Kevin A Heist; Craig J Galbán; Rajiv M Patel; Jianke Zhang; David G Beer; Brian D Ross; Alnawaz Rehemtulla; Stefanie Galbán
Journal:  Sci Signal       Date:  2015-01-27       Impact factor: 8.192

2.  Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis.

Authors:  Yves Matthess; Monika Raab; Rainald Knecht; Sven Becker; Klaus Strebhardt
Journal:  Mol Oncol       Date:  2014-01-17       Impact factor: 6.603

Review 3.  Mechanisms of cancer cell death induction by paclitaxel: an updated review.

Authors:  Shuang Zhao; Yufei Tang; Ruohan Wang; Masoud Najafi
Journal:  Apoptosis       Date:  2022-07-18       Impact factor: 5.561

4.  Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils.

Authors:  Jiyoung Oh; James S Malter
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

5.  Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.

Authors:  Roshan J Thapa; Shoko Nogusa; Peirong Chen; Jenny L Maki; Anthony Lerro; Mark Andrake; Glenn F Rall; Alexei Degterev; Siddharth Balachandran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

Review 6.  Necroptosis: an alternative cell death program defending against cancer.

Authors:  Dongshi Chen; Jian Yu; Lin Zhang
Journal:  Biochim Biophys Acta       Date:  2016-03-08

7.  Preferential Fas-mediated apoptotic execution at G1 phase: the resistance of mitotic cells to the cell death.

Authors:  T Hashimoto; K Juso; M Nakano; T Nagano; S Kambayashi; A Nakashima; U Kikkawa; S Kamada
Journal:  Cell Death Dis       Date:  2012-05-24       Impact factor: 8.469

8.  Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.

Authors:  Takeharu Ogura; Yoshiyuki Tanaka; Hiroki Tamaki; Mamoru Harada
Journal:  Int J Oncol       Date:  2016-04-08       Impact factor: 5.650

Review 9.  Killing a cancer: what are the alternatives?

Authors:  Peter Kreuzaler; Christine J Watson
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

Review 10.  Antimitotic drugs in the treatment of cancer.

Authors:  Rustelle Janse van Vuuren; Michelle H Visagie; Anne E Theron; Annie M Joubert
Journal:  Cancer Chemother Pharmacol       Date:  2015-11-12       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.